Bridging Science and Beauty

Autor: Christine C. Kim, Paul S. Yamauchi

Publikováno v: Textbook of Aging Skin ISBN: 9783642278143

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::320e86c1910359b10d9b7c8391f2c02f
https://doi.org/10.1007/978-3-662-47398-6_151

Predicting migraine responsiveness to botulinum toxin type A injections

Autor: Jeffrey S. Dover, Sue Ann Wee, Christine C. Kim, Megan M. Bogart, Rami Burstein, Kenneth A. Arndt

Publikováno v: Archives of dermatology. 146(2)

Background Botulinum toxin type A (BTX) is used prophylactically to reduce the frequency of migraine headaches, with inconsistent responses reported in the literature. The purpose of our study was to determine whether BTX injections at doses used for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1540325c9876b59528d690e2a34a6a7
https://pubmed.ncbi.nlm.nih.gov/21079079

Tetracarbonyliron(O) Complexes Containing Group V Donor Ligands

Autor: Michel O. Albers, Eric Singleton, Neil J. Coville, Carlton E. Ash, Christine C. Kim, Marcetta Y. Darensbourg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::666c70d8fa0c96f5c4950f12c59df1e8
https://doi.org/10.1002/9780470132593.ch44

Jurisdiction-level costs of the initial phase of the COVID-19 vaccination program in the United States, December 20, 2020-May 31, 2021.

Autor: Kim C; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: qee2@cdc.gov., Dunphy C; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA; National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA., Duggar C; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA., Pike J; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Publikováno v: Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126287. Date of Electronic Publication: 2024 Sep 03.

SARS-CoV-2 Infection and Other Communicable Diseases Identified Among Evacuees From Afghanistan Arriving in Virginia and Pennsylvania, August to September 2021.

Autor: Gearhart SL; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Preston LE; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Christensen DL; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kinzer MH; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Ohlsen EC; Division of Workforce Development, National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Alaska Department of Health, Anchorage, AK, USA., Kim C; Division of Workforce Development, National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Palo MR; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Rothney E; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Klevos AD; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Pieracci EG; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Hausman LB; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Rey A; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Division of State and Local Readiness, Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA., Sockwell D; Virginia Department of Health, Richmond, VA, USA., Lawman H; Philadelphia Department of Public Health, Philadelphia, PA, USA.; Nordisk, Philadelphia, PA, USA., Alvarado-Ramy F; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Brown C; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Gertz AM; Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Publikováno v: Public health reports (Washington, D.C. : 1974) [Public Health Rep] 2024 Sep 29, pp. 333549241277375. Date of Electronic Publication: 2024 Sep 29.